Roche Pharmaceutical Development and Sales Overview slide image

Roche Pharmaceutical Development and Sales Overview

YTD Sep 2022: Pharmaceuticals Division sales New products compensate for loss-of-exclusivity and COVID-19 sales decline Roche CER=Constant Exchange Rates 2022 2021 Change in % CHFM CHFM CHF CER Pharmaceuticals Division 33,189 33,379 -1 0 United States 17,199 16,707 3 -1 Europe 6,100 6,610 -8 -1 Japan 3,029 3,186 -5 7 International 6,861 6,876 0 0 17
View entire presentation